PRESTIGE CONSUMER HEALTHCARE INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943.4M | $963.0M | $975.8M |
| Cost of Revenue | $493.1M | $503.3M | $500.9M | $502.4M | $466.2M | $395.9M | $410.8M | $420.2M |
| Gross Profit | $595.6M | $634.5M | $624.4M | $625.3M | $620.6M | $547.5M | $552.2M | $555.6M |
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% | 57.3% | 56.9% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $116.4M | $108.2M | $106.2M | $107.4M | $107.5M | $83.1M | $89.1M | $89.8M |
| Operating Income | $309.4M | $336.8M | $342.4M | $-22.4M | $329.9M | $297.4M | $291.2M | $67.5M |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% |
| Interest Expense | — | $1.8M | $5.2M | $4.4M | $64.3M | $82.3M | $96.2M | $105.1M |
| Pretax Income | $257.5M | $284.2M | $276.0M | $-93.9M | $262.5M | $204.1M | $191.2M | $-38.1M |
| Income Tax Expense | $67.2M | $69.6M | $66.7M | $-11.6M | $57.1M | $39.4M | $48.9M | $-2.3M |
| Net Income | $190.3M | $214.6M | $209.3M | $-82.3M | $205.4M | $164.7M | $142.3M | $-35.8M |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 |
| Shares Outstanding (Basic) | 48.5M | 49.7M | 49.8M | 49.9M | 50.3M | 50.2M | 50.7M | 52.1M |
| Shares Outstanding (Diluted) | 48.7M | 50.1M | 50.2M | 49.9M | 50.8M | 50.6M | 51.1M | 52.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |